2bnh

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2bnh" size="450" color="white" frame="true" align="right" spinBox="true" caption="2bnh, resolution 2.3&Aring;" /> '''PORCINE RIBONUCLEASE ...)
Line 1: Line 1:
-
[[Image:2bnh.jpg|left|200px]]<br /><applet load="2bnh" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:2bnh.jpg|left|200px]]<br /><applet load="2bnh" size="350" color="white" frame="true" align="right" spinBox="true"
caption="2bnh, resolution 2.3&Aring;" />
caption="2bnh, resolution 2.3&Aring;" />
'''PORCINE RIBONUCLEASE INHIBITOR'''<br />
'''PORCINE RIBONUCLEASE INHIBITOR'''<br />
==Overview==
==Overview==
-
We describe the mechanism of ribonuclease inhibition by ribonuclease, inhibitor, a protein built of leucine-rich repeats, based on the crystal, structure of the complex between the inhibitor and ribonuclease A. The, structure was determined by molecular replacement and refined to an Rcryst, of 19.4% at 2.5 A resolution. Ribonuclease A binds to the concave region, of the inhibitor protein comprising its parallel beta-sheet and loops. The, inhibitor covers the ribonuclease active site and directly contacts, several active-site residues. The inhibitor only partially mimics the, RNase-nucleotide interaction and does not utilize the p1 phosphate-binding, pocket of ribonuclease A, where a sulfate ion remains bound. The 2550 A2, of accessible surface area buried upon complex formation may be one of the, major contributors to the extremely tight association (Ki = 5.9 x 10(-14), M). The interaction is predominantly electrostatic; there is a high, chemical complementarity with 18 putative hydrogen bonds and salt links, but the shape complementarity is lower than in most other protein-protein, complexes. Ribonuclease inhibitor changes its conformation upon complex, formation; the conformational change is unusual in that it is a plastic, reorganization of the entire structure without any obvious hinge and, reflects the conformational flexibility of the structure of the inhibitor., There is a good agreement between the crystal structure and other, biochemical studies of the interaction. The structure suggests that the, conformational flexibility of RI and an unusually large contact area that, compensates for a lower degree of complementarity may be the principal, reasons for the ability of RI to potently inhibit diverse ribonucleases., However, the inhibition is lost with amphibian ribonucleases that have, substituted most residues corresponding to inhibitor-binding residues in, RNase A, and with bovine seminal ribonuclease that prevents inhibitor, binding by forming a dimer.
+
We describe the mechanism of ribonuclease inhibition by ribonuclease inhibitor, a protein built of leucine-rich repeats, based on the crystal structure of the complex between the inhibitor and ribonuclease A. The structure was determined by molecular replacement and refined to an Rcryst of 19.4% at 2.5 A resolution. Ribonuclease A binds to the concave region of the inhibitor protein comprising its parallel beta-sheet and loops. The inhibitor covers the ribonuclease active site and directly contacts several active-site residues. The inhibitor only partially mimics the RNase-nucleotide interaction and does not utilize the p1 phosphate-binding pocket of ribonuclease A, where a sulfate ion remains bound. The 2550 A2 of accessible surface area buried upon complex formation may be one of the major contributors to the extremely tight association (Ki = 5.9 x 10(-14) M). The interaction is predominantly electrostatic; there is a high chemical complementarity with 18 putative hydrogen bonds and salt links, but the shape complementarity is lower than in most other protein-protein complexes. Ribonuclease inhibitor changes its conformation upon complex formation; the conformational change is unusual in that it is a plastic reorganization of the entire structure without any obvious hinge and reflects the conformational flexibility of the structure of the inhibitor. There is a good agreement between the crystal structure and other biochemical studies of the interaction. The structure suggests that the conformational flexibility of RI and an unusually large contact area that compensates for a lower degree of complementarity may be the principal reasons for the ability of RI to potently inhibit diverse ribonucleases. However, the inhibition is lost with amphibian ribonucleases that have substituted most residues corresponding to inhibitor-binding residues in RNase A, and with bovine seminal ribonuclease that prevents inhibitor binding by forming a dimer.
==About this Structure==
==About this Structure==
-
2BNH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa] with ACE as [http://en.wikipedia.org/wiki/ligand ligand]. This structure superseeds the now removed PDB entry 1BNH. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2BNH OCA].
+
2BNH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa] with <scene name='pdbligand=ACE:'>ACE</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. This structure supersedes the now removed PDB entry 1BNH. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNH OCA].
==Reference==
==Reference==
Line 19: Line 19:
[[Category: leucine-rich repeats]]
[[Category: leucine-rich repeats]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 08:50:36 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:39:44 2008''

Revision as of 14:39, 21 February 2008


2bnh, resolution 2.3Å

Drag the structure with the mouse to rotate

PORCINE RIBONUCLEASE INHIBITOR

Overview

We describe the mechanism of ribonuclease inhibition by ribonuclease inhibitor, a protein built of leucine-rich repeats, based on the crystal structure of the complex between the inhibitor and ribonuclease A. The structure was determined by molecular replacement and refined to an Rcryst of 19.4% at 2.5 A resolution. Ribonuclease A binds to the concave region of the inhibitor protein comprising its parallel beta-sheet and loops. The inhibitor covers the ribonuclease active site and directly contacts several active-site residues. The inhibitor only partially mimics the RNase-nucleotide interaction and does not utilize the p1 phosphate-binding pocket of ribonuclease A, where a sulfate ion remains bound. The 2550 A2 of accessible surface area buried upon complex formation may be one of the major contributors to the extremely tight association (Ki = 5.9 x 10(-14) M). The interaction is predominantly electrostatic; there is a high chemical complementarity with 18 putative hydrogen bonds and salt links, but the shape complementarity is lower than in most other protein-protein complexes. Ribonuclease inhibitor changes its conformation upon complex formation; the conformational change is unusual in that it is a plastic reorganization of the entire structure without any obvious hinge and reflects the conformational flexibility of the structure of the inhibitor. There is a good agreement between the crystal structure and other biochemical studies of the interaction. The structure suggests that the conformational flexibility of RI and an unusually large contact area that compensates for a lower degree of complementarity may be the principal reasons for the ability of RI to potently inhibit diverse ribonucleases. However, the inhibition is lost with amphibian ribonucleases that have substituted most residues corresponding to inhibitor-binding residues in RNase A, and with bovine seminal ribonuclease that prevents inhibitor binding by forming a dimer.

About this Structure

2BNH is a Single protein structure of sequence from Sus scrofa with as ligand. This structure supersedes the now removed PDB entry 1BNH. Full crystallographic information is available from OCA.

Reference

Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A., Kobe B, Deisenhofer J, J Mol Biol. 1996 Dec 20;264(5):1028-43. PMID:9000628

Page seeded by OCA on Thu Feb 21 16:39:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools